Low-Dose Rituximab May Keep RA Activity Low in Responders :

Rituximab doses as low as 200 mg were effective in treating rheumatoid arthritis, an extension study of a small trial in the Netherlands found.

Related Keywords

Netherlands , Maya Buch , Centre For Musculoskeletal Research , Radboud Institute For Health Sciences In Nijmegen , University Of Manchester England , American College Of Rheumatology , Maarten Clinic , Radboud Institute , Health Sciences , American College , Disease Activity Score , Experimental Medicine , Musculoskeletal Research , Rheumatoid Arthritis , A , Antineoplastic Drug , Nti Cancer Agents , Evacizumab , Rlotinib , Efitinib , Matinib , Ituximab , U11248 , Unitinib , Rastuzumab , Biologic Therapy , Monoclonal Antibody , Etuximab , Clinical Research , Clinical Trials , Linical Studies , Disease Modifying Antirheumatic Drugs Dmards , Mard Disease Modifying Antirheumatic Drug , Adverse Effects , Side Effects , C Reactive ,